• Exchange: Canadian Sec
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Immunall Science Inc

+ Add to Watchlist

GNS:CN

0.0100 CAD 0.00000.00%

As of 15:57:46 ET on 10/23/2014.

Snapshot for Immunall Science Inc (GNS)

Open: - Day's Range: - Volume: 2,000
Previous Close: 0.0100 52wk Range: 0.0050 - 0.0100 1-Yr Rtn: -

Stock Chart for GNS

No chart data available.
  • GNS:CN 0.0100
  • 1D
  • 1M
  • 1Y
0.0100
Interactive GNS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) 0.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 0.42
Shares Outstanding (M) 42.27
30 Day Average Volume 69
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/18/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNS

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for GNS

Immunall Science, Inc. manufactures a product from North American ginseng that can be added to any food product and produce the same effect as though it were consumed in a capsule.

M Frank PhilletChairman/President/CEOCraig McLennanChief Financial Officer
More Company Profile & Key Executives for GNS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement

Press Releases for GNS

Advertisement
Sponsored Links
Advertisements
sec ||= nil